nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0737	0.107	CbGbCtD
Indinavir—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0696	0.101	CbGbCtD
Indinavir—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0555	0.0803	CbGbCtD
Indinavir—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0555	0.0803	CbGbCtD
Indinavir—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0462	0.0668	CbGbCtD
Indinavir—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0462	0.0668	CbGbCtD
Indinavir—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0422	0.061	CbGbCtD
Indinavir—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0422	0.061	CbGbCtD
Indinavir—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0376	0.0544	CbGbCtD
Indinavir—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0354	0.0512	CbGbCtD
Indinavir—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.035	0.0506	CbGbCtD
Indinavir—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0239	0.0346	CbGbCtD
Indinavir—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0233	0.0337	CbGbCtD
Indinavir—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0228	0.033	CbGbCtD
Indinavir—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0204	0.0294	CbGbCtD
Indinavir—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0199	0.0288	CbGbCtD
Indinavir—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0188	0.0272	CbGbCtD
Indinavir—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0119	0.0173	CbGbCtD
Indinavir—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0113	0.0163	CbGbCtD
Indinavir—Lopinavir—CYP1A2—chronic obstructive pulmonary disease	0.00178	0.435	CrCbGaD
Indinavir—Nelfinavir—CYP1A2—chronic obstructive pulmonary disease	0.00165	0.405	CrCbGaD
Indinavir—Saquinavir—ALB—chronic obstructive pulmonary disease	0.000655	0.16	CrCbGaD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00131	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00131	CcSEcCtD
Indinavir—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00131	CcSEcCtD
Indinavir—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00131	CcSEcCtD
Indinavir—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00129	CcSEcCtD
Indinavir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000324	0.00129	CcSEcCtD
Indinavir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000324	0.00129	CcSEcCtD
Indinavir—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00129	CcSEcCtD
Indinavir—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00129	CcSEcCtD
Indinavir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00129	CcSEcCtD
Indinavir—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00129	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00128	CcSEcCtD
Indinavir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000321	0.00128	CcSEcCtD
Indinavir—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00128	CcSEcCtD
Indinavir—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00128	CcSEcCtD
Indinavir—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00127	CcSEcCtD
Indinavir—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00127	CcSEcCtD
Indinavir—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00127	CcSEcCtD
Indinavir—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00127	CcSEcCtD
Indinavir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00125	CcSEcCtD
Indinavir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00125	CcSEcCtD
Indinavir—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00125	CcSEcCtD
Indinavir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00125	CcSEcCtD
Indinavir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00124	CcSEcCtD
Indinavir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00124	CcSEcCtD
Indinavir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00124	CcSEcCtD
Indinavir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000311	0.00124	CcSEcCtD
Indinavir—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00124	CcSEcCtD
Indinavir—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00124	CcSEcCtD
Indinavir—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00123	CcSEcCtD
Indinavir—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.00123	CcSEcCtD
Indinavir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000308	0.00123	CcSEcCtD
Indinavir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.00123	CcSEcCtD
Indinavir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000307	0.00123	CcSEcCtD
Indinavir—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00122	CcSEcCtD
Indinavir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00122	CcSEcCtD
Indinavir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00121	CcSEcCtD
Indinavir—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00121	CcSEcCtD
Indinavir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000302	0.0012	CcSEcCtD
Indinavir—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.0012	CcSEcCtD
Indinavir—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.0012	CcSEcCtD
Indinavir—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000296	0.00118	CcSEcCtD
Indinavir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000295	0.00118	CcSEcCtD
Indinavir—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00118	CcSEcCtD
Indinavir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00117	CcSEcCtD
Indinavir—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000292	0.00117	CcSEcCtD
Indinavir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00116	CcSEcCtD
Indinavir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00116	CcSEcCtD
Indinavir—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00116	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00115	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00115	CcSEcCtD
Indinavir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00115	CcSEcCtD
Indinavir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00115	CcSEcCtD
Indinavir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00114	CcSEcCtD
Indinavir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00114	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00113	CcSEcCtD
Indinavir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00113	CcSEcCtD
Indinavir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00113	CcSEcCtD
Indinavir—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00113	CcSEcCtD
Indinavir—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00113	CcSEcCtD
Indinavir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00112	CcSEcCtD
Indinavir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00111	CcSEcCtD
Indinavir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00111	CcSEcCtD
Indinavir—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00111	CcSEcCtD
Indinavir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00111	CcSEcCtD
Indinavir—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000276	0.0011	CcSEcCtD
Indinavir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.0011	CcSEcCtD
Indinavir—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.0011	CcSEcCtD
Indinavir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00109	CcSEcCtD
Indinavir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00109	CcSEcCtD
Indinavir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00109	CcSEcCtD
Indinavir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00109	CcSEcCtD
Indinavir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00109	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00109	CcSEcCtD
Indinavir—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00108	CcSEcCtD
Indinavir—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00108	CcSEcCtD
Indinavir—Pain—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00108	CcSEcCtD
Indinavir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00108	CcSEcCtD
Indinavir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00108	CcSEcCtD
Indinavir—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00027	0.00108	CcSEcCtD
Indinavir—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00107	CcSEcCtD
Indinavir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00107	CcSEcCtD
Indinavir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00107	CcSEcCtD
Indinavir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00107	CcSEcCtD
Indinavir—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00106	CcSEcCtD
Indinavir—Pain—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00106	CcSEcCtD
Indinavir—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.00106	CcSEcCtD
Indinavir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000265	0.00106	CcSEcCtD
Indinavir—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00105	CcSEcCtD
Indinavir—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00105	CcSEcCtD
Indinavir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00105	CcSEcCtD
Indinavir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00105	CcSEcCtD
Indinavir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00105	CcSEcCtD
Indinavir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00104	CcSEcCtD
Indinavir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00104	CcSEcCtD
Indinavir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.00104	CcSEcCtD
Indinavir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00104	CcSEcCtD
Indinavir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00104	CcSEcCtD
Indinavir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00104	CcSEcCtD
Indinavir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00104	CcSEcCtD
Indinavir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00103	CcSEcCtD
Indinavir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00103	CcSEcCtD
Indinavir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00102	CcSEcCtD
Indinavir—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00102	CcSEcCtD
Indinavir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00101	CcSEcCtD
Indinavir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00101	CcSEcCtD
Indinavir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00101	CcSEcCtD
Indinavir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000251	0.001	CcSEcCtD
Indinavir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000251	0.001	CcSEcCtD
Indinavir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.001	CcSEcCtD
Indinavir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.001	CcSEcCtD
Indinavir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.000998	CcSEcCtD
Indinavir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.000989	CcSEcCtD
Indinavir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.000988	CcSEcCtD
Indinavir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000248	0.000988	CcSEcCtD
Indinavir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000247	0.000985	CcSEcCtD
Indinavir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.000985	CcSEcCtD
Indinavir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.000983	CcSEcCtD
Indinavir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00098	CcSEcCtD
Indinavir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00098	CcSEcCtD
Indinavir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.000978	CcSEcCtD
Indinavir—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00097	CcSEcCtD
Indinavir—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000965	CcSEcCtD
Indinavir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00095	CcSEcCtD
Indinavir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.000945	CcSEcCtD
Indinavir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.000945	CcSEcCtD
Indinavir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000234	0.000933	CcSEcCtD
Indinavir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.000933	CcSEcCtD
Indinavir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000233	0.000932	CcSEcCtD
Indinavir—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000929	CcSEcCtD
Indinavir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000229	0.000914	CcSEcCtD
Indinavir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.000909	CcSEcCtD
Indinavir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000228	0.000909	CcSEcCtD
Indinavir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000224	0.000896	CcSEcCtD
Indinavir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.000896	CcSEcCtD
Indinavir—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000894	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000894	CcSEcCtD
Indinavir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00089	CcSEcCtD
Indinavir—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000882	CcSEcCtD
Indinavir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000881	CcSEcCtD
Indinavir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00022	0.000877	CcSEcCtD
Indinavir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000866	CcSEcCtD
Indinavir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000866	CcSEcCtD
Indinavir—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000859	CcSEcCtD
Indinavir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.000858	CcSEcCtD
Indinavir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000849	CcSEcCtD
Indinavir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.000846	CcSEcCtD
Indinavir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00021	0.000837	CcSEcCtD
Indinavir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.000837	CcSEcCtD
Indinavir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00082	CcSEcCtD
Indinavir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000818	CcSEcCtD
Indinavir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.000805	CcSEcCtD
Indinavir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000202	0.000805	CcSEcCtD
Indinavir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.000798	CcSEcCtD
Indinavir—Rash—Formoterol—chronic obstructive pulmonary disease	0.0002	0.000798	CcSEcCtD
Indinavir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.0002	0.000798	CcSEcCtD
Indinavir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.000798	CcSEcCtD
Indinavir—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000798	CcSEcCtD
Indinavir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000199	0.000793	CcSEcCtD
Indinavir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.000793	CcSEcCtD
Indinavir—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000792	CcSEcCtD
Indinavir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.000791	CcSEcCtD
Indinavir—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00079	CcSEcCtD
Indinavir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000198	0.000789	CcSEcCtD
Indinavir—Rash—Montelukast—chronic obstructive pulmonary disease	0.000196	0.000782	CcSEcCtD
Indinavir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000196	0.000781	CcSEcCtD
Indinavir—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00078	CcSEcCtD
Indinavir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000195	0.000777	CcSEcCtD
Indinavir—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00077	CcSEcCtD
Indinavir—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000768	CcSEcCtD
Indinavir—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000766	CcSEcCtD
Indinavir—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000766	CcSEcCtD
Indinavir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00076	CcSEcCtD
Indinavir—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000758	CcSEcCtD
Indinavir—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000755	CcSEcCtD
Indinavir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000754	CcSEcCtD
Indinavir—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000754	CcSEcCtD
Indinavir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000753	CcSEcCtD
Indinavir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000188	0.000752	CcSEcCtD
Indinavir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.000752	CcSEcCtD
Indinavir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000749	CcSEcCtD
Indinavir—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.000739	CcSEcCtD
Indinavir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000185	0.000737	CcSEcCtD
Indinavir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00071	CcSEcCtD
Indinavir—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.000707	CcSEcCtD
Indinavir—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000705	CcSEcCtD
Indinavir—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000701	CcSEcCtD
Indinavir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000689	CcSEcCtD
Indinavir—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000686	CcSEcCtD
Indinavir—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000686	CcSEcCtD
Indinavir—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000675	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000663	CcSEcCtD
Indinavir—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000651	CcSEcCtD
Indinavir—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000634	CcSEcCtD
Indinavir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00062	CcSEcCtD
Indinavir—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00062	CcSEcCtD
Indinavir—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000616	CcSEcCtD
Indinavir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000611	CcSEcCtD
Indinavir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000586	CcSEcCtD
Indinavir—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000575	CcSEcCtD
Indinavir—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000567	CcSEcCtD
Indinavir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000565	CcSEcCtD
Indinavir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000564	CcSEcCtD
Indinavir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000561	CcSEcCtD
Indinavir—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000558	CcSEcCtD
Indinavir—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000551	CcSEcCtD
Indinavir—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000549	CcSEcCtD
Indinavir—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000548	CcSEcCtD
Indinavir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000545	CcSEcCtD
Indinavir—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000537	CcSEcCtD
Indinavir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00052	CcSEcCtD
Indinavir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00052	CcSEcCtD
Indinavir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000518	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000516	CcSEcCtD
Indinavir—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000514	CcSEcCtD
Indinavir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000505	CcSEcCtD
Indinavir—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000498	CcSEcCtD
Indinavir—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000498	CcSEcCtD
Indinavir—Shock—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00049	CcSEcCtD
Indinavir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000489	CcSEcCtD
Indinavir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000484	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000482	CcSEcCtD
Indinavir—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000475	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000454	CcSEcCtD
Indinavir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000453	CcSEcCtD
Indinavir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000451	CcSEcCtD
Indinavir—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000447	CcSEcCtD
Indinavir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000439	CcSEcCtD
Indinavir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000433	CcSEcCtD
Indinavir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000432	CcSEcCtD
Indinavir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000432	CcSEcCtD
Indinavir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00043	CcSEcCtD
Indinavir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00043	CcSEcCtD
Indinavir—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000426	CcSEcCtD
Indinavir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000411	CcSEcCtD
Indinavir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000407	CcSEcCtD
Indinavir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000407	CcSEcCtD
Indinavir—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.92e-05	0.000396	CcSEcCtD
Indinavir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000394	CcSEcCtD
Indinavir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000394	CcSEcCtD
Indinavir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.000367	CcSEcCtD
Indinavir—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000358	CcSEcCtD
Indinavir—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000353	CcSEcCtD
Indinavir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000341	CcSEcCtD
Indinavir—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.00033	CcSEcCtD
Indinavir—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000317	CcSEcCtD
Indinavir—Rash—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.000314	CcSEcCtD
Indinavir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000314	CcSEcCtD
Indinavir—Headache—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000312	CcSEcCtD
Indinavir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.78e-05	0.00145	CbGpPWpGaD
Indinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.6e-05	0.00142	CbGpPWpGaD
Indinavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.5e-05	0.0014	CbGpPWpGaD
Indinavir—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.49e-05	0.0014	CbGpPWpGaD
Indinavir—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.42e-05	0.00138	CbGpPWpGaD
Indinavir—Nausea—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000296	CcSEcCtD
Indinavir—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.39e-05	0.00138	CbGpPWpGaD
Indinavir—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.32e-05	0.00137	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	7.29e-05	0.00136	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.12e-05	0.00133	CbGpPWpGaD
Indinavir—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.04e-05	0.00131	CbGpPWpGaD
Indinavir—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.94e-05	0.00129	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.89e-05	0.00128	CbGpPWpGaD
Indinavir—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.83e-05	0.00127	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.79e-05	0.00127	CbGpPWpGaD
Indinavir—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.73e-05	0.00126	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.61e-05	0.00123	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.56e-05	0.00122	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	6.43e-05	0.0012	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.4e-05	0.00119	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.33e-05	0.00118	CbGpPWpGaD
Indinavir—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.25e-05	0.00116	CbGpPWpGaD
Indinavir—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.16e-05	0.00115	CbGpPWpGaD
Indinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.16e-05	0.00115	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.08e-05	0.00113	CbGpPWpGaD
Indinavir—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.06e-05	0.00113	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.98e-05	0.00112	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.95e-05	0.00111	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.9e-05	0.0011	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	5.79e-05	0.00108	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.77e-05	0.00108	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.74e-05	0.00107	CbGpPWpGaD
Indinavir—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.74e-05	0.00107	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.71e-05	0.00106	CbGpPWpGaD
Indinavir—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.69e-05	0.00106	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.67e-05	0.00106	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.66e-05	0.00106	CbGpPWpGaD
Indinavir—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.66e-05	0.00106	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.65e-05	0.00105	CbGpPWpGaD
Indinavir—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.62e-05	0.00105	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.61e-05	0.00105	CbGpPWpGaD
Indinavir—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.54e-05	0.00103	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	5.5e-05	0.00103	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.48e-05	0.00102	CbGpPWpGaD
Indinavir—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.44e-05	0.00101	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.42e-05	0.00101	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.38e-05	0.001	CbGpPWpGaD
Indinavir—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.37e-05	0.001	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.36e-05	0.000999	CbGpPWpGaD
Indinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.35e-05	0.000998	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.28e-05	0.000985	CbGpPWpGaD
Indinavir—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.23e-05	0.000976	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.21e-05	0.000971	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.19e-05	0.000968	CbGpPWpGaD
Indinavir—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.18e-05	0.000966	CbGpPWpGaD
Indinavir—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.16e-05	0.000963	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.13e-05	0.000956	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.11e-05	0.000954	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	5.05e-05	0.000941	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5e-05	0.000933	CbGpPWpGaD
Indinavir—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.96e-05	0.000925	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.000921	CbGpPWpGaD
Indinavir—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.89e-05	0.000913	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.83e-05	0.000901	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.76e-05	0.000889	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	4.7e-05	0.000876	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.69e-05	0.000875	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.67e-05	0.000871	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.64e-05	0.000865	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.61e-05	0.000861	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.5e-05	0.00084	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.44e-05	0.000828	CbGpPWpGaD
Indinavir—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.43e-05	0.000825	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.38e-05	0.000818	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.38e-05	0.000816	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.37e-05	0.000814	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.29e-05	0.0008	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.27e-05	0.000797	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.25e-05	0.000794	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.07e-05	0.00076	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	4.03e-05	0.000751	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.99e-05	0.000744	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.97e-05	0.000741	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.76e-05	0.000701	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.75e-05	0.0007	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.75e-05	0.000699	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.7e-05	0.000691	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.65e-05	0.000681	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.51e-05	0.000655	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.47e-05	0.000648	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.45e-05	0.000644	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.4e-05	0.000635	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.39e-05	0.000633	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.27e-05	0.00061	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.24e-05	0.000604	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.23e-05	0.000602	CbGpPWpGaD
Indinavir—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	3.17e-05	0.000592	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.17e-05	0.000591	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.16e-05	0.00059	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.12e-05	0.000583	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.12e-05	0.000582	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.08e-05	0.000574	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3e-05	0.00056	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.97e-05	0.000554	CbGpPWpGaD
Indinavir—ABCC1—Disease—KL—chronic obstructive pulmonary disease	2.95e-05	0.00055	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.92e-05	0.000545	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.91e-05	0.000543	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.9e-05	0.000541	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.88e-05	0.000536	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.85e-05	0.000532	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.85e-05	0.000531	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.83e-05	0.000528	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.82e-05	0.000526	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.8e-05	0.000523	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.77e-05	0.000517	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.77e-05	0.000516	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.76e-05	0.000514	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.75e-05	0.000514	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.73e-05	0.000508	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.71e-05	0.000505	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.67e-05	0.000497	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000493	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.63e-05	0.000491	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.63e-05	0.000491	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.63e-05	0.00049	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.62e-05	0.000489	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.62e-05	0.000489	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.59e-05	0.000484	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.57e-05	0.00048	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.57e-05	0.000479	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.56e-05	0.000477	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.54e-05	0.000473	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.5e-05	0.000466	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.49e-05	0.000464	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.44e-05	0.000454	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.41e-05	0.00045	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.4e-05	0.000448	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.39e-05	0.000446	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.31e-05	0.000432	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.29e-05	0.000427	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.29e-05	0.000427	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.25e-05	0.000419	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.24e-05	0.000417	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	2.21e-05	0.000412	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.2e-05	0.000409	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.19e-05	0.000409	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.16e-05	0.000403	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-05	0.000398	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.12e-05	0.000396	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.1e-05	0.000392	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.09e-05	0.00039	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.08e-05	0.000388	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.06e-05	0.000384	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.05e-05	0.000383	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.01e-05	0.000376	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.99e-05	0.000372	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.97e-05	0.000367	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.96e-05	0.000366	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.000357	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.91e-05	0.000356	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.91e-05	0.000356	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.91e-05	0.000355	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.88e-05	0.000352	CbGpPWpGaD
Indinavir—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.84e-05	0.000344	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.000338	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000335	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.78e-05	0.000332	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.76e-05	0.000328	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.75e-05	0.000327	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.74e-05	0.000325	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.73e-05	0.000322	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.7e-05	0.000316	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.66e-05	0.000311	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000309	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.000305	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.58e-05	0.000294	CbGpPWpGaD
Indinavir—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.55e-05	0.00029	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000289	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.54e-05	0.000287	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.52e-05	0.000284	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.5e-05	0.000281	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000277	CbGpPWpGaD
Indinavir—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.48e-05	0.000276	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.44e-05	0.000269	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.42e-05	0.000265	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000264	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.41e-05	0.000262	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.000261	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.39e-05	0.000259	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-05	0.000259	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.000258	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.38e-05	0.000257	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000254	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000253	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.32e-05	0.000246	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.3e-05	0.000242	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.29e-05	0.000242	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.28e-05	0.000239	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000238	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.000237	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000236	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.000233	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000232	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.23e-05	0.00023	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000224	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.18e-05	0.00022	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.00022	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000218	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.13e-05	0.000211	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.08e-05	0.000202	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.07e-05	0.000199	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.05e-05	0.000196	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000196	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000194	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000192	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000188	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.82e-06	0.000183	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.82e-06	0.000183	CbGpPWpGaD
Indinavir—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	9.8e-06	0.000183	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.74e-06	0.000182	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.69e-06	0.000181	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	9.61e-06	0.000179	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.6e-06	0.000179	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.58e-06	0.000179	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.3e-06	0.000174	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.27e-06	0.000173	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.16e-06	0.000171	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.08e-06	0.000169	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.03e-06	0.000168	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.95e-06	0.000167	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.56e-06	0.00016	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.48e-06	0.000158	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.36e-06	0.000156	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	8.18e-06	0.000153	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.83e-06	0.000146	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.7e-06	0.000144	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	7.38e-06	0.000138	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.42e-06	0.00012	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.33e-06	0.000118	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	6.32e-06	0.000118	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.17e-06	0.000115	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	6.05e-06	0.000113	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.9e-06	0.00011	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.9e-06	0.00011	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.82e-06	0.000109	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.77e-06	0.000108	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.6e-06	0.000104	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.56e-06	0.000104	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.52e-06	0.000103	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.8e-06	7.09e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.64e-06	6.79e-05	CbGpPWpGaD
